This study aimed to explore the association between serum 25-hydroxyvitamin D (25(OH)D) and insulin resistance as well as b-cell function in Chinese Han patients with newly diagnosed type 2 diabetes mellitus (T2DM). A total of 264 patients was included in this study. Serum 25(OH)D, plasma glucose, serum insulin and other biochemical parameters were assayed. Postprandial venous blood was collected after a mixed-nutrient load. Insulin resistance was assessed by the homeostasis model assessment for insulin resistance (HOMA-IR) and Matsuda insulin sensitivity index (Matsuda ISI). The b-cell function was assessed by the homeostasis model assessment for insulin secretion (HOMA-b) and the change in insulin divided by change in glucose from 0 to 30 min (DI0-30/DG0-30). Patients were divided into three groups according to tertiles of serum 25(OH)D levels. There were significant differences in HOMA-IR and Matsuda ISI among the three groups (HOMA-IR, p50.005; Matsuda ISI, p50.009). Pearson correlation analyses showed that serum 25(OH)D was negatively correlated with fasting serum insulin (FIns) (r520.209, p50.012) and HOMA-IR (r520.273, p50.001), and positively correlated with Matsuda ISI (r50.219, p50.009) only in the male population. Multiple stepwise regression analyses showed that in the male population, serum 25(OH)D was an independent predictor for both HOMA-IR and Matsuda ISI before and after adjustment for confounding factors, respectively (p,0.05 for both). This study indicates the association of vitamin D with insulin resistance in male patients with newly diagnosed T2DM, which may contribute to the understanding of the mechanism underlying the onset of T2DM in the Chinese Han population.
Type 2 diabetes mellitus (T2DM) has become one of the most common chronic diseases worldwide. By 2013, more than 300 million people had been affected by T2DM (1) . In China, there are more than 100 million patients with T2DM and the prevalence of this disease has substantially increased in past decades (2, 3) . Because T2DM leads to severe complications such as coronary heart disease, stroke, kidney failure and blindness, numerous studies have been carried out to focus on its pathogenesis.
A growing body of evidence has suggested the involvement of vitamin D in the decline of b-cell function and insulin resistance, which are considered as the major pathological processes of T2DM. An early study has suggested the role of dietary vitamin D in maintaining normal insulin secretion (4) . In humans, serum vitamin D levels have been demonstrated to be positively associated with both b-cell function and negatively associated with insulin resistance (5) (6) (7) (8) (9) . Moreover, vitamin D has been proven to protect against inflammation-induced impairment of b cells (10) and suppress the apoptosis of pancreatic b cells (11) . Additionally, vitamin D attenuates insulin resistance through its influences on glucose uptake in skeletal muscle, immunity and inflammatory reaction (12) .
Although vitamin D is related to the development of insulin resistance and the impairment of b-cell function, current clinical evidence has not supported the definitive role of vitamin D in the pathogenesis of T2DM (13) . Furthermore, relationships between vitamin D and insulin resistance as well as b-cell function vary among different racial and ethnic groups (14) . To explore the role of vitamin D in the onset of T2DM in the Chinese Han population, we therefore investigated the relationship between serum 25-hydroxyvitamin D3 (25(OH)D) and insulin resistance as well as b-cell function in patients with newly diagnosed T2DM. Multiple indices which were derived from a mixed-meal tolerance test (MMTT) were used to evaluate insulin resistance and b-cell function in this study.
MATERIALS AND METHODS
In this study, 264 patients including 140 males and 124 females were recruited from March 2014 to E-mail: hfww2001@163.com November 2017. All participants with an average age of 50.0469.43 y were in-patients with newly diagnosed T2DM, fulfilling the criteria of World Health Organization 1999, at the Department of Endocrinology of Anhui Provincial Hospital. The ethnicity of all participants was Han. To minimize the sunlight exposure disturbance on vitamin D, all blood samples were collected in either spring (from March to May) or autumn (from September to November). Participants were excluded from this study based on the following criteria: (1) individuals who had acute complications of T2DM, pancreatic disease, liver disease, renal disease, cancer or excessive fasting blood glucose; (2) individuals who had taken vitamin D, calcium, lipid lowering drugs, oral antidiabetic agents or insulin therapy; (3) individuals diagnosed with type 1 diabetes mellitus, secondary diabetes mellitus or gestational diabetes mellitus. This study was approved by the Ethic Committee of Anhui Provincial Hospital (approval number LLSC20140077) and carried out in accordance with the Declaration of Helsinki for experiments involving humans. Written informed consent was obtained from all participants before their inclusion in this study.
The height and weight of patients were measured by trained nurses. Body mass index (BMI) was calculated by dividing weight in kilograms (kg) by height in square meters (m 2 ). After overnight fasting for 10-12 h, venous blood samples were collected to assay total cholesterol (TC), triglyceride (TG), serum creatinine (Scr), calcium (Ca), fasting plasma glucose (FPG), fasting serum insulin (FIns), serum 25(OH)D and glycosylated hemoglobin A1c (HbA1c).To assess postprandial blood glucose level and insulin responses, the MMTT, which provides a more physiological stimulus than glucose alone (15), was performed and venous blood samples were obtained at 30 min and 2 h after a mixed-nutrient load for assaying the plasma glucose (30-min and 2-h postprandial glucose (2hPG)) and serum insulin (30-min and 2-h serum insulin).
Blood glucose was assayed by the glucose oxidase method. HbA1c was assayed by the high-pressure liquid chromatography method. Insulin was detected by chemiluminescence (Abbott i2000 SR, Abbott Park, IL). Serum 25(OH)D was assayed by radioimmunoassay (DiaSorin, Stillwater, MN). The inter-assay and intra-assay precision for 25(OH)D were 9.5% and 6.3%, respectively. The TC, TG, Scr and Ca were assayed using the Hitachi 7600 automatic biochemical analyzer (Hitachi Ltd., Tokyo, Japan).
The homeostatic model assessment for insulin secretion (HOMA-b) was used to assess b-cell function. The formula for HOMA-b was as follows: 203FIns (mIU/L)/ (FPG (mmol/L)23.5). The early insulin response to a mixed-nutrient load was calculated as the ratio of the change in insulin to the change in glucose from 0 to 30 min (DI0-30/DG0-30). Insulin resistance was assessed by both homeostasis model assessment for insulin resistance (HOMA-IR), which was calculated as FIns (mIU/L)3FPG (mmol/L)/22.5, and Matsuda insulin sensitivity index (Matsuda ISI), which was calculated according to the formula: 10,000/√(G03I0)3(G3I), where G and I are the average levels of plasma glucose and serum insulin of MMTT.
Data were examined for normal distribution by the Kolmogorov-Smirnov test before further analysis. Continuous normally distributed variables were presented as mean6standard deviation (SD). Skewed distributed data presented as median with interquartile range were natural logarithm transformed to normality for further analysis. All participants were divided into three groups according to the tertiles of serum 25(OH)D levels in the total population (T1, 3.5-10.5 ng/mL; T2, 10.5-16.0 ng/mL; T3, 16.0-33.9 ng/mL). One-way analysis of variance (ANOVA) was used to analyze the variables among the three groups. The ratio of male to female was analyzed by the Chi-squared (X 2 )-test. Pearson correlation analyses were used to examine the associations between serum 25(OH)D and various indices of glucose metabolism. Multiple linear stepwise regression analyses were performed to investigate the independent association of serum 25(OH)D with indices of insulin resistance (HOMA-IR and Matsuda ISI) using significant variables in the correlation analyses. BMI, TC, TG, FPG, 2hPG and Ca were chosen as confounding factors, since they have been shown to be related to insulin resistance. Three regression models were constructed, and these confounding factors were entered as follows: model 1 included BMI; model 2 included FPG and 2hPG; and model 3 included BMI, FPG, 2hPG, Ca, TC and TG. The statistical analyses were performed by SPSS 13.0 (SPSS Inc., Chicago, IL). Statistical significance was considered as p,0.05.
RESULTS
The average serum 25(OH)D level in this study was 13.4715.28 ng/mL. The anthropometrical and biochemical characteristics of total patients are shown in Table 1 To further evaluate whether the serum 25(OH)D was the independent predictor of insulin resistance and insulin sensitivity, multiple stepwise regression analyses were performed in the male population. As shown in Table 3 , serum 25(OH)D was an independent predictor for both HOMA-IR and Matsuda ISI after adjustment for confounding factors (p,0.05 for both).
DISCUSSION
Over the last decades, a number of clinical studies have described the involvement of vitamin D in the onset Skewed data were log transformed to normality before further analysis. of T2DM in both Eastern and Western populations. However, the definitive association between vitamin D and T2DM has also been doubted (16, 17) . Additionally, some Mendelian randomization studies and randomized placebo-controlled trials have challenged the causal association between vitamin D and T2DM (18) (19) (20) (21) . (22, 23) . Furthermore, 1,25-(OH)2-D activates transcription of the human insulin receptor gene, stimulates the expression of insulin receptor, and enhances insulin-mediated glucose transport (24) . Vitamin D may reduce insulin resistance by inhibiting the expression of peroxisome proliferator-activated receptor-g and the differentiation from preadipocytes to mature adipocytes (25) . Inflammation is one of the important pathological mechanisms of insulin resistance. Vitamin D could regulate the immunological reaction of macrophages and monocytes, reduce the concentration of interleukin-6 (IL-6), interleukin-1b and tumor necrosis factora (TNF-a), and thereby relieve inflammatory reaction (26, 27) . Consistently, low vitamin D status is associated with high levels of inflammatory factors such as IL-6, TNF-a, and C-reactive protein (28) (29) (30) . Remarkably, recent clinical trials have indicated that supplementation of vitamin D may reduce the risk of diabetes mellitus by attenuating the development of insulin resistance rather than by lowering insulin secretion, supporting the association of vitamin D with insulin resistance in the pathogenesis of T2DM (31) .
Additionally, the association of low vitamin D with increased insulin resistance and decreased insulin sensitivity could partly be attributed to its action on insulin secretion in pancreatic b-cells via Ca 21 . Vitamin D is essential for calcium homeostasis and insulin secretion is dependent on calcium oscillations (32) . Early study shows that the active form of vitamin D, 1,25(OH)2-vitamin D, stimulates insulin secretion in isolated rat pancreas (33 (34) . Moreover, 1,25(OH)2-vitamin D facilitates the insulin response to glucose via its regulatory effects on the calcium pool of b-cells intracellularly and extracellularly (35, 36) . A report by Beaulieu et al. further shows that glucose-stimulated insulin secretion is reduced in vitamin D-deficient rats in the presence of hypocalcemia (37) .
Another interesting finding in this study is the sex disparity in the relationship between vitamin D and the indices of glucose metabolism in the Chinese Han population. Significant associations of serum 25(OH)D with indices of glucose metabolism were observed in males, whereas such associations were lacking in females. Few studies have focused on the sex disparity in the relationship between vitamin D and insulin sensitivity and b-cell dysfunction up to now. Gao et al. has reported that the vitamin D level is significantly associated with female b-cell function, whereas in the male population, these associations are null (38) . For the Western population, vitamin D deficiency was found to be associated with decreased insulin production in males with T2DM (9) . This sex disparity may result from the differential effects on glycemic status and risk of type 2 diabetes by endogenous sex hormones (39) . Low testosterone has been reported to be associated with greater risks of insulin resistance (40) . Recent studies have indicated that serum 25(OH)D level is positively associated with testosterone level in males (41) . A study by Wang et al. in Chinese males has drawn a similar conclusion (42) . Our findings confirmed this conclusion (Supplemental Online Material, Table S1 ). Other factors that affect glucose metabolism and the risk for incidence of T2DM, such as physical activity, smoking, body composition and eating habits may also partly explain this sex disparity. Nevertheless, further studies are required to address this issue.
Some limitations of this study should be noted. Firstly, this study is cross-sectional, and the causal relationship between vitamin D and indices of glucose metabolism could not be proven. Secondly, lifestyles such as outdoor exercise, smoking, alcohol consumption and a diet containing high levels of saturated fat and sugar should be considered in future study. Thirdly, parathyroid hormone, which has been shown to influence insulin resistance, was not included in this study due to a lack of information on the participants' serum parathyroid hormone levels (43) . Finally, the sample size of this study was limited. Prospective studies with a large sample size are required to investigate the role of vitamin D in the onset of T2DM.
In conclusion, this study shows the association of vitamin D with the indices of glucose metabolism in Chinese Han patients with newly diagnosed T2DM. Notably, such associations are sex-specific. The positive association with Matsuda ISI and negative association with HOMA-IR suggest the possible role of vitamin D in the development of insulin resistance during the pathogenesis of T2DM in the male Chinese Han population.
